Karnani Pharmaceuticals Pvt Ltd Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Karnani Pharmaceuticals Pvt Ltd Pharmaceutical Export Portfolio Dataset — 2 Products, $662.8K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Karnani Pharmaceuticals Pvt Ltd — Pharmaceutical Exporter Profile (2026) | 2 Products, $662.8K Trade | TransData Nexus

Karnani Pharmaceuticals Pvt Ltd

Indian Pharmaceutical Exporter · Ayurvedic & Herbal Products Specialist · $662.8K Total Trade · DGFT Verified

Karnani Pharmaceuticals Pvt Ltd is an Indian pharmaceutical exporter with a total trade value of $662.8K across 2 products in 1 therapeutic categories. Based on 170 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Ayurvedic ($331.4K), Herbal ($331.4K), .

Karnani Pharmaceuticals Pvt Ltd — Export Portfolio & Destination Treemap

Karnani Pharmaceuticals Pvt Ltd pharmaceutical export portfolio — 2 products across 1 therapeutic categories. Source: Indian Customs (DGFT).

Who is Karnani Pharmaceuticals Pvt Ltd? — Company Overview & Market Position

Karnani Pharmaceuticals Pvt Ltd, established on May 17, 1983, is a privately held pharmaceutical company headquartered in Mumbai, Maharashtra, India. The company is registered under the Corporate Identification Number (CIN) U24239MH1983PTC029997. It operates as a private limited company, classified as a non-government entity. The authorized capital stands at ₹20 million, with a paid-up capital of ₹14 million. As of the latest available data, the company employs approximately 58 professionals. The registered office is located at 19/23 Vithoba Lane, Vithal Wadi, Mumbai, Maharashtra, 400002, India.

Karnani Pharmaceuticals specializes in the manufacturing of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. The company's product portfolio is predominantly focused on Ayurvedic and Herbal products, reflecting a strong commitment to traditional medicine. This strategic focus is evident in their export data, where Ayurvedic and Herbal products each account for $331,000 in export value, collectively representing 100% of their export portfolio.

What Does Karnani Pharmaceuticals Pvt Ltd Export? — Product Portfolio Analysis

Top Products by Export Value

1Ayurvedic$331.4K

Product Portfolio — Top 2 by Export Value

Karnani Pharmaceuticals Pvt Ltd exports 2 pharmaceutical products across 1 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Ayurvedic	Ayurvedic & Herbal Products	$331.4K	85	1.4%	12
2	Herbal	Ayurvedic & Herbal Products	$331.4K	85	1.8%	12

Karnani Pharmaceuticals Pvt Ltd exports 2 pharmaceutical products across 1 therapeutic categories with a total export value of $662.8K. The top category is Ayurvedic & Herbal Products (100.0% of portfolio), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Karnani Pharmaceuticals Pvt Ltd — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Karnani Pharmaceuticals operates manufacturing units in Bhiwadi, Rajasthan, and Dehradun, Uttarakhand. These facilities are equipped to produce a range of pharmaceutical formulations, including tablets, capsules, syrups, and injections. The Bhiwadi unit is situated in the Bhiwadi Industrial Area, while the Dehradun unit's specific location details are not publicly disclosed.

3Key Leadership

The company is led by two directors:

Dr. Madanmohan Karnani: Founder and Director, Dr. Karnani established the company in 1983 and has been instrumental in its strategic planning, marketing (both domestic and export), and procurement activities.

Mr. Ajay Ashok Karnani: Director since 1986, Mr. Karnani manages production, general administration, and finance, contributing significantly to the company's growth and operational efficiency.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Karnani Pharmaceuticals Pvt Ltd Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Karnani Pharmaceuticals' export data indicates a focus on Ayurvedic and Herbal products, each accounting for $331,000 in export value, collectively representing 100% of their export portfolio. This suggests a strategic emphasis on these product categories in their international markets.

2Emerging Markets

The company's export data does not provide specific insights into its presence in emerging markets such as Africa, Latin America, or Southeast Asia. However, the focus on Ayurvedic and Herbal products positions Karnani Pharmaceuticals to potentially tap into these regions, where there is a growing interest in traditional and natural health products.

3Geographic Strategy

Karnani Pharmaceuticals' export data reveals a concentrated portfolio, with Ayurvedic and Herbal products each accounting for $331,000 in export value, collectively representing 100% of their export portfolio. This indicates a strategic focus on these product categories in their international markets.

Karnani Pharmaceuticals Pvt Ltd — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific details regarding Karnani Pharmaceuticals' FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history are not publicly available. The company's export data does not provide insights into its presence in the U.S. market. Given the focus on Ayurvedic and Herbal products, it is possible that the company is targeting markets with a demand for traditional and natural health products.

2WHO & EU GMP

Information regarding Karnani Pharmaceuticals' compliance with World Health Organization (WHO) prequalification, European Union Good Manufacturing Practice (EU GMP) certificates, and European Directorate for the Quality of Medicines & HealthCare (EDQM) status is not publicly available. The company's export data does not provide insights into its presence in regulated markets such as the EU.

3CDSCO & Indian Regulatory

Specific details regarding Karnani Pharmaceuticals' compliance with the Central Drugs Standard Control Organisation (CDSCO) manufacturing licenses, state drug controller approvals, and export No Objection Certificates (NOCs) are not publicly available. The company's export data does not provide insights into its regulatory standing within India.

Karnani Pharmaceuticals Pvt Ltd — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Karnani Pharmaceuticals operates in the Ayurvedic and Herbal product segments, which are competitive markets with numerous players. While specific competitors are not identified in the available data, the company's focus on these traditional product categories positions it in a niche market segment. The export data indicates a concentrated portfolio, with Ayurvedic and Herbal products each accounting for $331,000 in export value, collectively representing 100% of their export portfolio.

2Key Differentiators

Karnani Pharmaceuticals' emphasis on Ayurvedic and Herbal products distinguishes it in the pharmaceutical industry. This focus aligns with the growing global interest in natural and traditional health solutions. The company's strategic concentration on these product categories, as evidenced by its export data, reflects a commitment to leveraging traditional medicine in its offerings.

3Strategic Position

Karnani Pharmaceuticals' strategic direction appears to be centered on the production and export of Ayurvedic and Herbal pharmaceutical formulations. This focus suggests a commitment to traditional medicine and natural health products. The company's export data, with Ayurvedic and Herbal products each accounting for $331,000 in export value, collectively representing 100% of their export portfolio, indicates a concentrated approach to its international market presence.

Buyer Due Diligence Brief — Evaluating Karnani Pharmaceuticals Pvt Ltd as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Specific details regarding Karnani Pharmaceuticals' track record, export volume consistency, and reliability indicators are not publicly available. The company's export data indicates a focus on Ayurvedic and Herbal products, each accounting for $331,000 in export value, collectively representing 100% of their export portfolio.

2Certifications to Verify

Importers should verify the following certifications to ensure product quality and regulatory compliance:

FDA Facility Registration: Confirm the company's registration with the U.S. Food and Drug Administration.

WHO-GMP Certification: Verify compliance with World Health Organization Good Manufacturing Practices.

EU GMP Certification: Ensure adherence to European Union Good Manufacturing Practices.

Frequently Asked Questions — Karnani Pharmaceuticals Pvt Ltd

How many pharmaceutical products does Karnani Pharmaceuticals Pvt Ltd export from India?

Karnani Pharmaceuticals Pvt Ltd exports 2 pharmaceutical products across 1 therapeutic categories. The top exports are Ayurvedic ($331.4K), Herbal ($331.4K). Total export value is $662.8K.

What is Karnani Pharmaceuticals Pvt Ltd's total pharmaceutical export value?

Karnani Pharmaceuticals Pvt Ltd's total pharmaceutical export value is $662.8K, based on 170 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Karnani Pharmaceuticals Pvt Ltd cover?

Karnani Pharmaceuticals Pvt Ltd exports across 1 therapeutic categories. The largest are Ayurvedic & Herbal Products (100.0%, 2 products).

Get Full Karnani Pharmaceuticals Pvt Ltd Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.